6004

CN:COM:KPC

KPC Pharmaceuticals

  • Stock

Last Close

15.08

22/11 07:00

Market Cap

12.73B

Beta: -

Volume Today

14.99M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
584.03M
-
527.16M
9.74%
552.51M
4.81%
739.10M
33.77%
997.80M
35.00%
1.15B
15.63%
1.30B
12.91%
1.57B
20.87%
1.80B
14.36%
1.78B
1.02%
1.68B
5.48%
average payables
428.34M
-
421.64M
1.56%
433.03M
2.70%
495.44M
14.41%
621.16M
25.37%
765.20M
23.19%
787.20M
2.88%
786.53M
0.09%
1.03B
31.10%
1.11B
7.44%
820.92M
25.90%
average receivables
594.50M
-
659.73M
10.97%
797.39M
20.87%
966.88M
21.26%
1.23B
27.10%
1.53B
24.34%
1.74B
13.56%
1.88B
8.37%
2.24B
18.86%
2.80B
25.09%
3.07B
9.81%
book value per share
2.70
-
2.44
9.68%
4.20
72.11%
4.51
7.43%
4.67
3.42%
4.97
6.51%
5.51
10.91%
5.86
6.37%
6.31
7.68%
6.56
3.98%
6.99
6.46%
capex per share
-0.33
-
-0.28
13.48%
-0.27
5.45%
-0.26
3.49%
-0.34
32.57%
-0.28
17.38%
-0.46
61.45%
-0.21
54.17%
-0.31
49.07%
-0.13
57.00%
-0.09
35.55%
capex to depreciation
-4.71
-
-3.99
15.29%
-2.74
31.27%
-2.51
8.46%
-2.84
12.92%
-2.17
23.48%
-2.81
29.61%
-1.05
62.60%
-1.28
22.14%
-0.49
62.08%
-0.31
37.10%
capex to operating cash flow
-0.88
-
-0.59
33.08%
-0.44
24.80%
-0.65
47.82%
-1.11
69.46%
-0.62
44.31%
-0.81
31.05%
-0.39
52.12%
-0.94
142.40%
-0.40
57.30%
-0.18
55.07%
capex to revenue
-0.06
-
-0.05
8.79%
-0.04
20.75%
-0.04
6.99%
-0.05
15.12%
-0.03
33.38%
-0.04
39.83%
-0.02
51.92%
-0.03
39.12%
-0.01
57.07%
-0.01
30.13%
cash per share
0.51
-
0.63
22.02%
0.85
36.54%
0.99
16.16%
1.00
0.46%
1.54
54.62%
1.95
26.27%
2.38
22.34%
2.29
3.86%
2.61
13.79%
2.77
6.17%
days of inventory on hand
81.26
-
61.83
23.91%
69.83
12.95%
100.58
44.03%
128.42
27.67%
120.40
6.25%
125.36
4.13%
144.65
15.38%
141.91
1.90%
126.65
10.75%
141.81
11.97%
days payables outstanding
61.97
-
52.11
15.91%
51.46
1.26%
62.65
21.75%
79.91
27.56%
84.61
5.88%
65.63
22.43%
69.37
5.69%
93.31
34.51%
73.63
21.09%
55.84
24.17%
days sales outstanding
61.79
-
63.13
2.16%
65.50
3.76%
75.25
14.89%
87.70
16.53%
84.80
3.31%
81.84
3.49%
91.77
12.14%
111.89
21.91%
134.95
20.61%
147.29
9.15%
debt to assets
0.01
-
0.04
303.03%
0.10
131.69%
0.08
13.43%
0.10
22.21%
0.10
2.41%
0.08
18.60%
0.09
9.83%
0.09
3.92%
0.12
29.77%
0.12
2.75%
debt to equity
0.02
-
0.07
285.84%
0.15
120.28%
0.13
12.02%
0.18
39.14%
0.18
1.82%
0.14
20.04%
0.16
13.12%
0.17
5.87%
0.23
32.12%
0.21
6.97%
dividend yield
0.01
-
0.01
0.05%
0.00
68.09%
0.02
285.72%
0.02
32.58%
0.01
53.98%
0.01
30.94%
0.03
101.99%
0.02
11.67%
0.02
11.23%
0.01
64.47%
earnings yield
0.03
-
0.03
1.01%
0.03
10.23%
0.04
42.62%
0.05
19.33%
0.07
58.66%
0.06
23.16%
0.07
25.11%
0.06
12.85%
0.04
41.04%
0.03
21.34%
enterprise value
7.38B
-
9.35B
26.77%
15.44B
65.09%
10.32B
33.17%
7.09B
31.26%
4.13B
41.81%
7.50B
81.88%
5.82B
22.43%
7.63B
31.01%
10.20B
33.75%
15.49B
51.88%
enterprise value over ebitda
20.71
-
21.08
1.78%
25.01
18.66%
17.53
29.93%
12.96
26.05%
7.19
44.49%
10.23
42.18%
8.27
19.13%
8.46
2.25%
12.39
46.55%
22.62
82.49%
ev to operating cash flow
30.48
-
24.66
19.09%
32.39
31.32%
33.15
2.37%
29.24
11.81%
11.72
59.92%
17.47
49.09%
14.20
18.73%
30.31
113.44%
40.18
32.56%
42.60
6.04%
ev to sales
2.06
-
2.27
10.27%
3.14
38.38%
2.02
35.59%
1.21
40.09%
0.58
52.05%
0.92
59.07%
0.75
18.39%
0.92
22.50%
1.23
33.29%
2.03
64.89%
free cash flow per share
0.05
-
0.20
339.49%
0.34
70.24%
0.14
59.48%
-0.03
124.42%
0.18
625.80%
0.11
38.46%
0.33
206.67%
0.02
93.84%
0.20
882.58%
0.39
96.24%
free cash flow yield
0.00
-
0.02
317.89%
0.02
6.11%
0.01
40.28%
-0.00
135.82%
0.03
903.09%
0.01
65.42%
0.04
280.41%
0.00
95.17%
0.01
668.95%
0.02
32.84%
graham net net
0.10
-
0.38
279.16%
0.04
89.58%
0.27
583.51%
-0.20
175.58%
0.09
142.57%
0.61
601.39%
0.79
30.70%
0.82
3.34%
1.09
32.54%
1.77
63.15%
graham number
4.65
-
4.51
3.03%
7.10
57.44%
7.24
1.96%
6.64
8.27%
6.99
5.19%
8.60
23.15%
8.91
3.58%
9.76
9.49%
8.63
11.49%
9.60
11.23%
income quality
1.03
-
1.23
19.99%
1.11
10.32%
0.76
31.24%
0.72
4.80%
1.03
42.45%
0.92
10.89%
0.89
3.40%
0.49
44.72%
0.66
34.34%
0.82
24.15%
intangibles to total assets
0.10
-
0.11
13.48%
0.08
25.65%
0.10
17.31%
0.10
5.57%
0.10
2.65%
0.10
1.98%
0.08
15.70%
0.08
3.43%
0.07
16.32%
0.06
2.38%
interest coverage
13.29
-
30.26
127.70%
23.76
21.49%
21.19
10.81%
17.46
17.59%
10.12
42.06%
13.36
32.04%
18.55
38.84%
18.88
1.79%
12.21
35.35%
19.33
58.36%
interest debt per share
0.08
-
0.17
127.51%
0.63
262.49%
0.60
5.18%
0.86
42.82%
0.95
10.94%
0.85
10.77%
1.00
17.33%
1.14
14.05%
1.55
36.74%
1.52
2.32%
inventory turnover
4.49
-
5.90
31.43%
5.23
11.47%
3.63
30.57%
2.84
21.68%
3.03
6.66%
2.91
3.96%
2.52
13.33%
2.57
1.93%
2.88
12.05%
2.57
10.69%
invested capital
0.02
-
0.07
285.84%
0.15
120.28%
0.13
12.02%
0.18
39.14%
0.18
1.82%
0.14
20.04%
0.16
13.12%
0.17
5.87%
0.23
32.12%
0.21
6.97%
market cap
7.68B
-
9.79B
27.46%
15.70B
60.43%
10.65B
32.15%
7.24B
32.08%
4.64B
35.93%
8.17B
76.21%
6.57B
19.62%
8.37B
27.50%
10.72B
28.03%
15.81B
47.53%
net current asset value
1.05B
-
928.02M
11.76%
1.39B
49.56%
1.57B
13.10%
1.49B
4.99%
1.26B
15.66%
1.70B
35.23%
2.04B
20.17%
2.23B
8.97%
2.48B
11.19%
3.13B
26.20%
net debt to ebitda
-0.85
-
-0.99
15.79%
-0.43
56.19%
-0.57
32.89%
-0.27
53.83%
-0.89
234.96%
-0.91
1.89%
-1.06
16.93%
-0.83
21.86%
-0.63
23.83%
-0.47
25.48%
net income per share
0.36
-
0.37
4.11%
0.53
44.02%
0.52
3.22%
0.42
18.65%
0.44
3.88%
0.60
36.73%
0.60
0.85%
0.67
11.33%
0.50
24.66%
0.59
16.21%
operating cash flow per share
0.37
-
0.48
29.28%
0.60
25.72%
0.39
34.71%
0.31
21.77%
0.46
48.35%
0.56
23.19%
0.54
4.28%
0.33
38.50%
0.33
0.71%
0.48
43.43%
payables turnover
5.89
-
7.00
18.92%
7.09
1.27%
5.83
17.86%
4.57
21.61%
4.31
5.55%
5.56
28.91%
5.26
5.38%
3.91
25.65%
4.96
26.72%
6.54
31.87%
receivables turnover
5.91
-
5.78
2.11%
5.57
3.62%
4.85
12.96%
4.16
14.19%
4.30
3.42%
4.46
3.61%
3.98
10.83%
3.26
17.97%
2.70
17.09%
2.48
8.38%
research and ddevelopement to revenue
0.01
-
0.00
29.37%
0.01
141.51%
0.02
93.68%
0.01
37.75%
0.01
0.56%
0.01
5.28%
0.02
61.84%
0.01
26.83%
0.01
30.95%
0.01
0.44%
return on tangible assets
0.09
-
0.11
22.17%
0.09
14.70%
0.08
9.97%
0.06
30.50%
0.05
6.79%
0.07
25.23%
0.06
9.47%
0.06
1.18%
0.04
29.81%
0.05
13.93%
revenue per share
5.51
-
5.22
5.14%
6.23
19.30%
6.47
3.77%
7.45
15.16%
9.24
24.02%
10.66
15.46%
10.17
4.68%
10.89
7.15%
10.91
0.16%
10.06
7.76%
roe
0.13
-
0.15
15.27%
0.13
16.32%
0.11
9.92%
0.09
21.34%
0.09
2.47%
0.11
23.28%
0.10
5.19%
0.11
3.39%
0.08
27.55%
0.08
9.16%
roic
0.12
-
0.14
12.60%
0.10
24.83%
0.09
13.92%
0.08
12.92%
0.08
2.81%
0.10
26.68%
0.09
7.51%
0.09
1.94%
0.07
28.49%
0.06
9.82%
sales general and administrative to revenue
0.02
-
0.02
11.27%
0.01
16.61%
0.01
5.02%
0.02
5.31%
0.01
8.19%
0.01
9.99%
0.02
23.63%
0.01
7.98%
0.01
30.40%
0.01
0.94%
shareholders equity per share
2.70
-
2.44
9.68%
4.20
72.11%
4.51
7.43%
4.67
3.42%
4.97
6.51%
5.51
10.91%
5.86
6.37%
6.31
7.68%
6.56
3.98%
6.99
6.46%
stock based compensation to revenue
-0.11
-
tangible asset value
1.60B
-
1.72B
7.35%
2.93B
70.72%
3.09B
5.54%
3.13B
1.22%
3.27B
4.38%
3.61B
10.60%
3.94B
9.00%
4.24B
7.60%
4.52B
6.63%
5.07B
12.13%
tangible book value per share
2.46
-
2.18
11.42%
3.72
70.73%
3.92
5.55%
3.98
1.60%
4.25
6.67%
4.75
11.69%
5.19
9.32%
5.60
7.81%
5.96
6.43%
6.69
12.28%
working capital
1.09B
-
993.64M
8.44%
1.84B
84.89%
2.01B
9.29%
2.02B
0.53%
1.73B
14.14%
2.02B
16.81%
2.44B
20.39%
2.70B
10.59%
2.88B
6.77%
3.39B
17.70%

All numbers in (except ratios and percentages)